Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TBA-354 有抗结核作用,对结核分枝杆菌 H37Rv 菌株具有活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 263 | 现货 | ||
2 mg | ¥ 393 | 现货 | ||
5 mg | ¥ 747 | 现货 | ||
10 mg | ¥ 1,230 | 现货 | ||
25 mg | ¥ 2,250 | 现货 | ||
50 mg | ¥ 3,730 | 现货 | ||
100 mg | ¥ 5,360 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 821 | 现货 |
产品描述 | TBA-354 is anti-tuberculous and active against Mycobacterium tuberculosis strain H37Rv. |
体外活性 | TBA-354 is narrow spectrum and bactericidal in vitro against replicating and nonreplicating Mycobacterium tuberculosis, with potency similar to that of delamanid and greater than that of PA-824. TBA-354 maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and Clinicalal drug-sensitive and drug-resistant isolates [1]. TBA-354 is 5 to 10 times more potent than PA-824, but selected mutants are cross-resistant to PA-824 and delamanid. TBA-354 is 2 to 4 times more potent than PA-824 when combined with bedaquiline, and when administered at a dose equivalent to that of PA-824, TBA-354 demonstrated superior sterilizing efficacy [2]. |
体内活性 | TBA-354 has high bioavailability and a long elimination half-life. In vitro studies suggest a low risk of drug-drug interactions. Low-dose aerosol infection models of acute and chronic murine tuberculosis reveal time- and dose-dependent in vivo bactericidal activity that is at least as potent as that of delamanid and more potent than that of PA-824. |
别名 | TBA 354 |
分子量 | 436.34 |
分子式 | C19H15F3N4O5 |
CAS No. | 1257426-19-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (126.05 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2918 mL | 11.459 mL | 22.9179 mL | 57.2948 mL |
5 mM | 0.4584 mL | 2.2918 mL | 4.5836 mL | 11.459 mL | |
10 mM | 0.2292 mL | 1.1459 mL | 2.2918 mL | 5.7295 mL | |
20 mM | 0.1146 mL | 0.5729 mL | 1.1459 mL | 2.8647 mL | |
50 mM | 0.0458 mL | 0.2292 mL | 0.4584 mL | 1.1459 mL | |
100 mM | 0.0229 mL | 0.1146 mL | 0.2292 mL | 0.5729 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TBA-354 1257426-19-9 Microbiology/Virology Antibiotic Antibacterial inhibit Inhibitor TBA354 Bacterial TBA 354 inhibitor